Taiwan to start clinical trials on antiviral drug remdesivir
Taipei, Feb. 26 (CNA) National Taiwan University Hospital (NTUH) has consulted with the United States and is to start clinical trials in Taiwan of the antiviral drug remdesivir for the treatment of COVID-19 coronavirus, the Central Epidemic Command Center (CECC) said Wednesday.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Taiwan shares close up 0.2%12/11/2023 01:53 PM
Parties draw lots for placement on Taiwan's presidential ballot12/11/2023 12:32 PM
Mercury forecast to soar past 30 degrees Monday in western Taiwan12/11/2023 11:49 AM
U.S. dollar up in Taipei trading12/11/2023 10:24 AM
Taiwan headline news12/11/2023 10:22 AM